In this study, we systemically characterized CD27+IgD+ B cells in RA, revealing their numerical deficiency, natural antibody-like IgM-producing capacity impairment, BCR repertoire alteration as well as gene expression profile bias that would exacerbate the disease progression. The gene discussed is CD27; the disease is rheumatoid arthritis.